Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Compelling ERISA Arbitration No Sure Thing, 9th Circ. Shows No Photo Available

Kellie Mejdrich

The Ninth Circuit aligned with several other federal appeals courts when it recently struck down a clause in a food service company's ... (more story)

A Free Exercise 'Blueprint' In Colo. Abortion Reversal Order No Photo Available

Mark Payne

A Colorado federal judge's decision to allow medication abortion "reversals" on free exercise grounds could serve as a model for other... (more story)

'Shocked' By Eye-Watering Fines, Fed. Judges Redo FCA Math No Photo Available

Dan McKay

District courts handling big-dollar False Claims Act cases are increasingly wrestling with the Eighth Amendment ban on excessive fines... (more story)